Dmitry Balyasny’s CME Group CME Stock Holding History

Dmitry Balyasny’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.02M	Buy	+18,200	New	+$5.03M	0.01%	1474
2026 Q1	–	Sell	-3,500	Closed	-$956K	–	2964
2025 Q4	$956K	Buy	3,500 +2,100	+150%	+$571K	﹤0.01%	2222
2025 Q3	$378K	Hold	1,400	–	–	﹤0.01%	2499
2025 Q2	$386K	Sell	1,400 -112,200	-99%	-$30.5M	﹤0.01%	2394
2025 Q1	$30.1M	Buy	+113,600	New	+$28M	0.05%	444
2023 Q2	–	Sell	-3,400	Closed	-$651K	–	2336
2023 Q1	$651K	Sell	3,400 -29,400	-90%	-$5.32M	﹤0.01%	1879
2022 Q4	$5.52M	Buy	32,800 +3,400	+12%	+$591K	0.02%	986
2022 Q3	$5.21M	Buy	29,400 +11,900	+68%	+$2.35M	0.02%	970
2022 Q2	$3.58M	Buy	+17,500	New	+$3.71M	0.01%	1090
2016 Q2	–	Sell	-120,000	Closed	-$11.5M	–	1196
2016 Q1	$11.5M	Buy	+120,000	New	+$10.9M	0.07%	358

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dmitry Balyasny's CME Position: Q2 2026 in Review

Dmitry Balyasny reduced its CME Group (CME) stake by 85% in Q2 2026, selling an estimated $109M and leaving 70,710 shares worth $15.6M. The position accounts for 0.02% of the portfolio, ranked #841.

Dmitry Balyasny first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $284M in Q3 2024. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Dmitry Balyasny held 70,710 shares of CME Group worth $15.6M as of Q2 2026.
Dmitry Balyasny sold 393,914 CME Group shares in Q2 2026, an estimated $109M.
CME Group made up 0.02% of Dmitry Balyasny's portfolio in Q2 2026, its #841 holding.
Dmitry Balyasny first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
Dmitry Balyasny's CME Group position peaked at $284M in Q3 2024.
1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.